Diva Shah
Research Subjects
Diva Shah has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Anisha Gehani
Department of Radiology, Tata Medical Center, Kolkata, West Bengal, India
1 shared publication - Drushi Joshi
GIC Prime, Ahmedabad, India
1 shared publication Drushi Patel
Department of Radiology, Gujarat Imaging Center and Post Graduate Institute of Radiology and Imaging, Ahmedabad, Gujarat, India
1 shared publicationDushyant Mandlik
Department of Head and Neck Surgical Oncology, HCG Aastha Cancer Center, Ahmedabad, Gujarat, India
1 shared publication- Harsh Shah
Apollo Hospital International Limited, Ahmedabad, India
1 shared publication - Jignesh Dubal
HCG Cancer Centre, AHMEDABAD, India
1 shared publication
Latest Publications
- Open Access
- 24 April 2026
- Published by Georg Thieme Verlag KG in Indian Journal of Radiology and Imaging
Potential of Retrospective Fusion of FDG PET and Abbreviated MRI in Posttreatment Oral Cancer Follow-Up Using NI-RADS: Largest Case Series from a Tertiary Cancer Center in Western India
The present study aims to evaluate the effectiveness of retrospective positron emission tomography/magnetic resonance (PET/MR) fusion, in conjunction with the Neck Imaging Reporting and Data System (NI-RADS) classification system, to improve diagnostic accuracy and facilitate the detection of recurrence in patients with oral cancer. This retrospective study analyzed 106 patients with surgically treated oral cavity malignancies followed by adjuvant chemotherapy and/or radiotherapy and under surveillance for 9 to 12 months. In all patients, PET data was fused with postcontrast magnetic resonance imaging (MRI) images using automated software, and various MRI sequences were analyzed. Statistical analysis was performed using GraphPad Prism (version 10.2). Majority of patients were male (90.6%), aged 51 to 60 years (30.2%), with single lesions (96.2%). Histopathology confirmed 70% malignant and 30% benign lesions. MRI had high concordance with pathology in NI-RADS grade I (90.5%) but struggled with higher grades. PET showed similar trends, with increasing discordance in intermediate-risk cases. PET/MR fusion outperformed both modalities, achieving the highest concordance rates, especially in grades I (88.2%), II (93.3%), and IV (100%). PET/MR fusion demonstrated superior diagnostic performance with 96.1% sensitivity, 87.88% specificity, and 93.64% accuracy. Receiver operating characteristic analysis confirmed its superiority (area under the ROC curve: 0.948). PET/MR fusion offers superior detection rates for recurrent tumors in oral cancer surveillance, in comparison to PET and MRI alone with NI-RADS category I and II, while MRI with diffusion-weighted imaging excels in identifying perineural spread and locoregional extension. By leveraging both modalities, it minimizes false negatives and facilitates earlier interventions, improving patient outcomes.
- 24 April 2026
- Published by Georg Thieme Verlag KG in Indian Journal of Radiology and Imaging
Open AccessPotential of Retrospective Fusion of FDG PET and Abbreviated MRI in Posttreatment Oral Cancer Follow-Up Using NI-RADS: Largest Case Series from a Tertiary Cancer Center in Western India
The present study aims to evaluate the effectiveness of retrospective positron emission tomography/magnetic resonance (PET/MR) fusion, in conjunction with the Neck Imaging Reporting and Data System (NI-RADS) classification system, to improve diagnostic accuracy and facilitate the detection of recurrence in patients with oral cancer. This retrospective study analyzed 106 patients with surgically treated oral cavity malignancies followed by adjuvant chemotherapy and/or radiotherapy and under surveillance for 9 to 12 months. In all patients, PET data was fused with postcontrast magnetic resonance imaging (MRI) images using automated software, and various MRI sequences were analyzed. Statistical analysis was performed using GraphPad Prism (version 10.2). Majority of patients were male (90.6%), aged 51 to 60 years (30.2%), with single lesions (96.2%). Histopathology confirmed 70% malignant and 30% benign lesions. MRI had high concordance with pathology in NI-RADS grade I (90.5%) but struggled with higher grades. PET showed similar trends, with increasing discordance in intermediate-risk cases. PET/MR fusion outperformed both modalities, achieving the highest concordance rates, especially in grades I (88.2%), II (93.3%), and IV (100%). PET/MR fusion demonstrated superior diagnostic performance with 96.1% sensitivity, 87.88% specificity, and 93.64% accuracy. Receiver operating characteristic analysis confirmed its superiority (area under the ROC curve: 0.948). PET/MR fusion offers superior detection rates for recurrent tumors in oral cancer surveillance, in comparison to PET and MRI alone with NI-RADS category I and II, while MRI with diffusion-weighted imaging excels in identifying perineural spread and locoregional extension. By leveraging both modalities, it minimizes false negatives and facilitates earlier interventions, improving patient outcomes.
- Open Access
- 3 March 2026
- Published by Georg Thieme Verlag KG in Journal of Gastrointestinal and Abdominal Radiology
- Vol. 09 (03) , 291-301
Practical Imaging Approach to Complex Pelvic Lesions: The Onco-surgeons' Perspective
The pelvis is an anatomically intricate region comprising multiple organ systems, complex fascial planes, and densely packed neurovascular structures. Tumors arising in this region—such as soft tissue neoplasms, sarcomas, and metastatic lesions—pose significant diagnostic and surgical challenges due to their deep location, large size at presentation, and proximity to critical anatomical structures. Compared with appendicular skeletal tumors, pelvic neoplasms demand meticulous preoperative planning to achieve oncologic clearance while preserving function. A compartment-based anatomical framework, grounded in embryological development and surgical fascial planes, offers a systematic method for tumor localization, staging, and treatment planning. Although widely used in surgical oncology, this compartmental approach is underutilized in radiologic practice. Advances in high-resolution magnetic resonance imaging (MRI) and hybrid imaging modalities such as positron emission tomography-computed tomography (PET-CT) now enable radiologists to apply compartmental principles effectively. MRI's superior soft-tissue contrast delineates fascial boundaries and tumor infiltration with precision, while PET-CT provides essential metabolic information for nodal staging and treatment monitoring. This case-based review explores the imaging evaluation of pelvic tumors across anterior, middle, and posterior compartments, emphasizing the relevance of fascial anatomy—including the mesorectal, presacral, Denonvilliers', and rectovaginal fasciae—in guiding surgical planning. Specific attention is given to the radiologic depiction of these fascial planes, their embryological significance, and their impact on operative strategies such as nerve-sparing techniques and compartmental resections. Understanding pelvic compartmental anatomy through imaging enhances interdisciplinary communication, aids in selecting optimal surgical planes, and ultimately improves oncologic and functional outcomes in patients with complex pelvic malignancies, as demonstrated through selected case illustrations.
- 3 March 2026
- Published by Georg Thieme Verlag KG in Journal of Gastrointestinal and Abdominal Radiology
- Vol. 09 (03) , 291-301
Open AccessPractical Imaging Approach to Complex Pelvic Lesions: The Onco-surgeons' Perspective
The pelvis is an anatomically intricate region comprising multiple organ systems, complex fascial planes, and densely packed neurovascular structures. Tumors arising in this region—such as soft tissue neoplasms, sarcomas, and metastatic lesions—pose significant diagnostic and surgical challenges due to their deep location, large size at presentation, and proximity to critical anatomical structures. Compared with appendicular skeletal tumors, pelvic neoplasms demand meticulous preoperative planning to achieve oncologic clearance while preserving function. A compartment-based anatomical framework, grounded in embryological development and surgical fascial planes, offers a systematic method for tumor localization, staging, and treatment planning. Although widely used in surgical oncology, this compartmental approach is underutilized in radiologic practice. Advances in high-resolution magnetic resonance imaging (MRI) and hybrid imaging modalities such as positron emission tomography-computed tomography (PET-CT) now enable radiologists to apply compartmental principles effectively. MRI's superior soft-tissue contrast delineates fascial boundaries and tumor infiltration with precision, while PET-CT provides essential metabolic information for nodal staging and treatment monitoring. This case-based review explores the imaging evaluation of pelvic tumors across anterior, middle, and posterior compartments, emphasizing the relevance of fascial anatomy—including the mesorectal, presacral, Denonvilliers', and rectovaginal fasciae—in guiding surgical planning. Specific attention is given to the radiologic depiction of these fascial planes, their embryological significance, and their impact on operative strategies such as nerve-sparing techniques and compartmental resections. Understanding pelvic compartmental anatomy through imaging enhances interdisciplinary communication, aids in selecting optimal surgical planes, and ultimately improves oncologic and functional outcomes in patients with complex pelvic malignancies, as demonstrated through selected case illustrations.
- 2 August 2025
- Published by Springer Nature in Indian Journal of Surgical Oncology
- Vol. 17 (5) , 1045-1051
Outcomes of Pelvic Exenteration for Recurrent or Persistent Cervical Cancer: Revisiting Curative approach in the Era of Advancing Palliative Options
This study aimed to evaluate the outcomes of pelvic exenteration (PE) in patients with recurrent or persistent cervical cancer, with emphasis on whether modern advancements—timely diagnosis, surgical refinement, and multidisciplinary perioperative care—have addressed traditional concerns regarding morbidity, quality of life, and survival. This was a retrospective study conducted at a tertiary cancer center from January 2021 to December 2023. In total, 25 patients who underwent PE for recurrent (60%) or persistent (40%) cervical cancer were included. All patients were evaluated with PET-CT and pelvic MRI for operability. Tissue diagnosis was confirmed using TRUS, TVS, EUA, or cystoscopic biopsy. Surgical outcomes, complications, margin status, survivals, and quality of life were assessed using EORTC QLQ-C30 and Stoma-QOL tools. Median age was 58 years. Total PE was performed in 56%, anterior in 40%, and posterior in 4%; 28% were robotic. R0 resection was achieved in 100%. Major complications occurred in 8%, with no perioperative mortality. Mean operative time was 6.4 h and mean blood loss was 650 ml. At a median follow-up of 18.5 months, 76% of patients were alive and 72% were disease free. Median DFS and OS were 18.5 months. QoL improved significantly over time, with global health scores increasing from 69.5 to 80.8, and stoma-related QoL indices from 77.7 to 83.3%. With modern advances, PE offers a curative option with acceptable morbidity and improved quality of life. It should be actively considered in eligible patients rather than deferred in favor of palliative systemic therapies.
- 2 August 2025
- Published by Springer Nature in Indian Journal of Surgical Oncology
- Vol. 17 (5) , 1045-1051
Outcomes of Pelvic Exenteration for Recurrent or Persistent Cervical Cancer: Revisiting Curative approach in the Era of Advancing Palliative Options
This study aimed to evaluate the outcomes of pelvic exenteration (PE) in patients with recurrent or persistent cervical cancer, with emphasis on whether modern advancements—timely diagnosis, surgical refinement, and multidisciplinary perioperative care—have addressed traditional concerns regarding morbidity, quality of life, and survival. This was a retrospective study conducted at a tertiary cancer center from January 2021 to December 2023. In total, 25 patients who underwent PE for recurrent (60%) or persistent (40%) cervical cancer were included. All patients were evaluated with PET-CT and pelvic MRI for operability. Tissue diagnosis was confirmed using TRUS, TVS, EUA, or cystoscopic biopsy. Surgical outcomes, complications, margin status, survivals, and quality of life were assessed using EORTC QLQ-C30 and Stoma-QOL tools. Median age was 58 years. Total PE was performed in 56%, anterior in 40%, and posterior in 4%; 28% were robotic. R0 resection was achieved in 100%. Major complications occurred in 8%, with no perioperative mortality. Mean operative time was 6.4 h and mean blood loss was 650 ml. At a median follow-up of 18.5 months, 76% of patients were alive and 72% were disease free. Median DFS and OS were 18.5 months. QoL improved significantly over time, with global health scores increasing from 69.5 to 80.8, and stoma-related QoL indices from 77.7 to 83.3%. With modern advances, PE offers a curative option with acceptable morbidity and improved quality of life. It should be actively considered in eligible patients rather than deferred in favor of palliative systemic therapies.